CGM: Key Takeaways
- Cgms cleared by the FDA in 2024 as over-the-counter devices for adults not using insulin.
- A CGM shows real-time glucose responses that can meaningfully inform dietary choices for people with prediabetes or insulin resistance.
- For metabolically healthy users, CGM data often confirms normal function but may create anxiety about typical post-meal spikes.
- A CGM cannot diagnose insulin resistance or replace bloodwork like A1C tests for a complete metabolic health picture.
Continuous glucose monitors, small sensors originally developed for people managing diabetes, are now sold directly to consumers without a diabetes diagnosis, marketed as a general metabolic health and nutrition tool. Dexcom’s Stelo and Abbott’s Lingo were cleared by the FDA in 2024 as over-the-counter devices for adults who don’t use insulin.
Table of Contents
The technology genuinely works, measuring glucose levels continuously via a small sensor worn on the arm rather than through periodic finger-prick testing. What’s more debatable is how much a metabolically healthy person actually learns from that data that changes anything meaningful.
What a CGM Actually Measures and How
A CGM sensor sits just under the skin, typically on the back of the upper arm, and measures glucose levels in the interstitial fluid (the fluid between cells) continuously, sending readings to a paired phone app throughout the day and night. This gives a much more complete picture than a single blood glucose test at one point in time, showing how glucose rises and falls in response to specific meals, exercise, sleep, and stress throughout an entire day.
The Genuine Value for Someone With Prediabetes or Insulin Resistance Concerns
For someone with prediabetes, a family history of type 2 diabetes, or other specific risk factors, seeing real-time glucose response to individual foods and meals can meaningfully inform dietary choices in a way general nutrition advice can’t, since glucose response to the same food varies notably between individuals based on genetics, gut microbiome, and other factors. This population is the group CGMs were adapted for use beyond diagnosed diabetes, and the data has genuine, actionable value for them specific to managing an actual elevated risk.
What a Healthy Person’s Data Usually Shows
A person without diabetes or prediabetes, with normal insulin function, typically sees glucose spikes after meals that return to a normal baseline within a predictable window, which is exactly how a healthy metabolic system is supposed to work. For this group, a CGM often confirms that the body is functioning normally rather than revealing an actionable problem, and some healthy users report the data creating unnecessary anxiety about entirely normal post-meal glucose fluctuations that don’t indicate any health issue at all.
The Marketing Gap Worth Being Aware Of
Consumer CGM marketing sometimes implies that any post-meal glucose spike, even a completely normal and temporary one, is inherently something to minimize or be concerned about, a framing not well-supported for metabolically healthy individuals by current research. Normal, temporary glucose elevation after eating is expected physiology, not a warning sign, and treating every spike as a problem to engineer away through food choices can lead to overly restrictive eating patterns without a clear corresponding health benefit for someone whose metabolic baseline is already normal.
What a CGM Cannot Tell a Non-Diabetic User
A CGM measures glucose specifically; it does not diagnose insulin resistance, measure metabolic health broadly, or replace bloodwork like an A1C test or fasting insulin levels, which give a more complete and clinically validated picture of long-term metabolic health than glucose trend data alone. Someone genuinely concerned about metabolic health is better served combining any CGM data with actual bloodwork and a conversation with a doctor, rather than relying on glucose trends in isolation to assess overall health.
A Practical Approach to Deciding
- A CGM has clearer, more established value for someone with prediabetes, insulin resistance, or a specific doctor-recommended reason to monitor glucose closely.
- For a metabolically healthy person, treat the data as curiosity and general feedback, not a diagnostic tool, and avoid over-interpreting normal post-meal spikes as problems.
- Pair any CGM use with actual bloodwork for a genuine picture of metabolic health, rather than relying on glucose trends alone.
- Watch for the specific pattern of dietary anxiety or over-restriction that some healthy users report developing from over-interpreting normal glucose fluctuations.
The Honest Trade-Off
A continuous glucose monitor is a genuinely useful tool for a specific population with real metabolic risk factors, and a more ambiguous, sometimes counterproductive one for an already healthy person seeking general wellness insight. The technology’s expansion into general consumer health tracking has outpaced the evidence for how useful, or how potentially anxiety-inducing, that specific use case actually is for people without an underlying metabolic concern.
Bottom Line
A CGM offers clear value for those with prediabetes or insulin resistance but serves mainly as curiosity for metabolically healthy people. Pair any monitoring with bloodwork and a doctor conversation to assess metabolic health properly.
Related Reading
- Drinking a Liter of Water Can Change What Your Smart Scale Says About Your Body Fat. Here’s What These Numbers Actually Measure.
- The FDA Cleared AirPods Pro 2 as a Real Hearing Aid. It Costs $249. The Alternative Averages $4,600.
- The Oura Ring 5 Costs More Than $399. Here’s the Real Number.
Sources: MedTech Dive on the FDA’s first over-the-counter CGM clearance, Dexcom announcement.
Photo credit: “My new TRUE2go glucose meter fits onto the canister of test strips!” by sylvar, licensed BY (https://creativecommons.org/licenses/by/2.0/). Source: https://www.flickr.com/photos/44124401501@N01/6647425155
